
    
      The study was an interventional single center double-blinded human randomized trial with two
      groups treated parallel.The first group received an intramuscular injection of
      Methylprednisolone 40 mg/ml 2ml x 1 as a single dose. The second group received an
      intramuscular injection of NaCl 0,9 mg/ml 2ml x 1 as a single dose. Symptom score and the use
      of medication was registered daily during the pollen peak of the season, using an electronic
      diary. The study was conducted during the spring of 2019.
    
  